Assessing the Potential Impact of Commercialization of COVID-19 Vaccines on Vaccine Access
NASHP
MARCH 6, 2023
This imminent shift will pose significant cost and access barriers for individuals, particularly for those who are underinsured or uninsured or face difficulties in accessing a regular health care provider. During the PHE, public and private insurers were required to cover the administration of COVID-19 vaccines with no cost sharing.
Let's personalize your content